Short Description Billionaire co‑author of ‘Juvenescence’ investing in gerotherapeutics.
Description UK investor Jim Mellon co‑founded Juvenescence PLC, deploying $300 m across 20+ longevity startups spanning cell therapy, senolytics, and AI drug discovery. His book ‘Juvenescence’ and keynote talks at SALT and Milken persuade traditional asset managers to diversify into aging science. Mellon lobbies HM Treasury for tax incentives on longevity R&D and funds the Oxford Longevity Project.